Abbott实验室在问题3中赚取了1.30美元的股本,提高了2025年的利润前景,提高了红利。 Abbott Labs earned $1.30/share in Q3, raised 2025 profit outlook, and raised dividend.

Abbott实验室报告,Q3收入为每股1.30美元,达到了预期水平,收入为113.7亿美元,比上一年增加6.9%。 Abbott Laboratories reported Q3 earnings of $1.30 per share, meeting expectations, with $11.37 billion in revenue, up 6.9% year-over-year. 该公司将其2025年全年EPS准则提高到5.12至5.18美元,而分析员预计为5.14美元。 The company raised its 2025 full-year EPS guidance to $5.12–$5.18, while analysts expect $5.14. 机构投资者集体拥有公司75.18%的股份,一些公司增加了股份,包括马萨诸塞金融公司和合并银行。 Institutional investors collectively own 75.18% of the company, with several firms increasing their stakes, including Massachusetts Financial Services and Amalgamated Bank. Abbott宣布每股季度红利为0.59美元,收益率为1.9%,并维持“机动购买”共识评级,平均价格目标为147美元。 Abbott announced a quarterly dividend of $0.59 per share, yielding 1.9%, and maintains a "Moderate Buy" consensus rating with a $147.00 average price target. 股票交易额为124.42美元,市场上限为216.55亿美元。 The stock trades at $124.42 with a market cap of $216.55 billion.